Engelhardt, MD, PhD, FRCA, T., Zaarour, MD, C. and Crawford, MBBS, FRCPC, M.W. 2017. Plasma cyclic guanosine 3′,5′-monophosphate levels: A marker of glutamate-nitric oxide-guanyl cyclase activity?. Journal of Opioid Management. 7, 6 (Nov. 2017), 462–466. DOI:https://doi.org/10.5055/jom.2011.0087.